ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

November 9, 1979

NCI Issues Alert On Stage 2/3 Rectal Cancer Therapy

March 22, 1991

Sense Of Excitement, Challenges, Mark Healy’s Debut

April 26, 1991

Responses So Far Support Outstanding Investigator Grant; NCAB Members Object To Salary commitment

July 8, 1983

Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials.

May 11, 2001

Report Questions Effectiveness Of Bimanual Pelvic Exam

March 31, 2006